{"url":"https://lda.senate.gov/api/v1/filings/06695f1b-eaaf-44cd-9549-e13db3194261/","filing_uuid":"06695f1b-eaaf-44cd-9549-e13db3194261","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2025,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/06695f1b-eaaf-44cd-9549-e13db3194261/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Cristina Antelo","dt_posted":"2026-01-20T16:49:08-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"309 Pennsylvania Avenue SE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":401104769,"url":"https://lda.senate.gov/api/v1/registrants/401104769/","house_registrant_id":null,"name":"FEROX STRATEGIES","description":"Government relations.","address_1":"309 Pennsylvania Avenue SE","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CRISTINA ANTELO","contact_telephone":"+1 202-320-8236","dt_updated":"2026-01-28T11:09:33.549398-05:00"},"client":{"id":64985,"url":"https://lda.senate.gov/api/v1/clients/64985/","client_id":64985,"name":"FRESENIUS KABI USA LLC","general_description":"Generic and biosimilar pharmaceutical manufacturer","client_government_entity":null,"client_self_select":false,"state":"IL","state_display":"Illinois","country":"US","country_display":"United States of America","ppb_state":"IL","ppb_state_display":"Illinois","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-13"},"lobbying_activities":[{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"General issues related to trade.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67961,"prefix":null,"prefix_display":null,"first_name":"CRISTINA","nickname":null,"middle_name":null,"last_name":"ANTELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71787,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146075,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"TAGGART","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"General healthcare issues related to biosimilar industries.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67961,"prefix":null,"prefix_display":null,"first_name":"CRISTINA","nickname":null,"middle_name":null,"last_name":"ANTELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71787,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146075,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"TAGGART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152876,"prefix":"mr","prefix_display":"MR.","first_name":"ZACHARY","nickname":null,"middle_name":"BENJAMIN","last_name":"FRIEND","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"General patent issues related to biosimilar industries.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67961,"prefix":null,"prefix_display":null,"first_name":"CRISTINA","nickname":null,"middle_name":null,"last_name":"ANTELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71787,"prefix":null,"prefix_display":null,"first_name":"MARK","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146075,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"TAGGART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152876,"prefix":"mr","prefix_display":"MR.","first_name":"ZACHARY","nickname":null,"middle_name":"BENJAMIN","last_name":"FRIEND","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}